


Healthcare News Roundup: Generic
HSMN NewsFeed - 18 Jan 2007
Barr Receives Tentative Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
Barr Receives Tentative Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
HSMN NewsFeed - 5 Jan 2007
Savient Pharmaceuticals Restructures Commercial Operations Following Launch of Authorized Generic
Savient Pharmaceuticals Restructures Commercial Operations Following Launch of Authorized Generic
HSMN NewsFeed - 3 Jan 2007
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
HSMN NewsFeed - 29 Dec 2006
Bradley Pharmaceuticals Announces Launch of Authorized Generic of Pamine(R) (methscopolamine bromide)
Bradley Pharmaceuticals Announces Launch of Authorized Generic of Pamine(R) (methscopolamine bromide)
HSMN NewsFeed - 29 Dec 2006
Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
HSMN NewsFeed - 28 Dec 2006
Boca Pharmacal Receives FDA Approval for Generic Pamine(R) and Pamine(R) Forte Tablets
Boca Pharmacal Receives FDA Approval for Generic Pamine(R) and Pamine(R) Forte Tablets
HSMN NewsFeed - 27 Dec 2006
Dr. Reddy's Announces Final Approval of Ondansetron Tablets with 180-Days of Marketing Exclusivity
Dr. Reddy's Announces Final Approval of Ondansetron Tablets with 180-Days of Marketing Exclusivity
HSMN NewsFeed - 26 Dec 2006
Par Pharmaceutical Receives Approval for Ondansetron Orally Disintegrating Tablets
Par Pharmaceutical Receives Approval for Ondansetron Orally Disintegrating Tablets
HSMN NewsFeed - 21 Dec 2006
Ranbaxy Granted Final FDA Approval to Market Simvastatin 5, 10, 20 and 40 mg Tablets
Ranbaxy Granted Final FDA Approval to Market Simvastatin 5, 10, 20 and 40 mg Tablets
HSMN NewsFeed - 20 Dec 2006
Australian Federal Court Grants Favorable Decision to Ranbaxy on Pfizer's Atorvastatin Patent
Australian Federal Court Grants Favorable Decision to Ranbaxy on Pfizer's Atorvastatin Patent
HSMN NewsFeed - 19 Dec 2006
Reliant Pharmaceuticals Files Patent Infringement Lawsuit Against Par Pharmaceutical
Reliant Pharmaceuticals Files Patent Infringement Lawsuit Against Par Pharmaceutical
HSMN NewsFeed - 19 Dec 2006
Endo Pharmaceuticals Submits Citizen Petition to FDA Regarding Lidoderm(R)
Endo Pharmaceuticals Submits Citizen Petition to FDA Regarding Lidoderm(R)
HSMN NewsFeed - 15 Dec 2006
Caraco Pharmaceutical Laboratories Ltd. to Market Extended Phenytoin Sodium Capsules, USP 100mg
Caraco Pharmaceutical Laboratories Ltd. to Market Extended Phenytoin Sodium Capsules, USP 100mg
HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
HSMN NewsFeed - 28 Nov 2006
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
